Author

Timo Minssen

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founder and Managing Director of UCPH’s Center for Advanced Studies in Biomedical Innovation Law (CeBIL). He is also affiliated with Lund University as a researcher in Quantum Law. His research concentrates on Intellectual Property, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors including biologics and biosimilars. His studies comprise a plethora of legal issues emerging in the lifecycle of biotechnological and medical products and processes – from the regulation of research and incentives for innovation to technology transfer and commercialization.
  • Biotechnology

    Innovation and Intellectual Property Policies in European Research Infrastructure Consortia

    By Timo Minssen I am happy to announce the publication of our collaborative paper with Helen Yu and Jakob Wested on “Innovation and intellectual property policies in European Research Infrastructure Consortia (part I)” in the Journal of…

    Innovation and Intellectual Property Policies in European Research Infrastructure Consortia

    By

    Timo Minssen

  • Environment

    Bold New Policies for The Brave New Biologies: IPRs and Innovation in Synthetic Biology and Gene editing

    Research Seminar at the University of Copenhagen debating intellectual property and innovation in synthetic biology, systems biology & gene editing. New technologies in biology offer a brave new world of possibilities. Promising solutions to some of…

    Bold New Policies for The Brave New Biologies: IPRs and Innovation in Synthetic Biology and Gene editing

    By

    Timo Minssen

  • Bioethics

    Global Genes, Local Concerns: A Symposium on Legal, Ethical and Scientific Challenges in International Biobanking

    I am happy to announce our “Global Genes, Local Concerns Symposium on Legal, Ethical and Scientific Challenges in International Biobanking” to be held at the University of Copenhagen (DK) on 16 March 2017, 08:00-18:30. Among the many…

    Global Genes, Local Concerns: A Symposium on Legal, Ethical and Scientific Challenges in International Biobanking

    By

    Timo Minssen

  • Call for Abstracts

    Call for Papers – European Pharmaceutical Law Review (EPLR)

    Dear Colleagues, I am happy to announce that I have just joined the Board of Editors of the new journal “European Pharmaceutical Law Review” (EPLR). One of my first tasks is to spread the news about our “Call…

    Call for Papers – European Pharmaceutical Law Review (EPLR)

    By

    Timo Minssen

  • Biotechnology

    Standards, Data Exchange and Intellectual Property Rights in Systems Biology

    By Timo Minssen I am happy to announce that our recent paper on “Standards, Data Exchange and Intellectual Property Rights in Systems Biology” has been published in the Biotechnology Journal Vol 11, Issue 12, pp. 1477-1480.  The…

    Standards, Data Exchange and Intellectual Property Rights in Systems Biology

    By

    Timo Minssen

  • Generic Drugs

    Legal Dimensions of Big Data in the Health and Life Sciences

    By Timo Minssen Please find below my welcome speech at last-weeks mini-symposium on “Legal dimensions of Big Data in the Health and Life Sciences – From Intellectual Property Rights and Global Pandemics to Privacy and Ethics at the University of Copenhagen…

    Legal Dimensions of Big Data in the Health and Life Sciences

    By

    Timo Minssen

  • Affordable Care Act

    Separating sheep from goats- a European view on the patent eligibility of biomedical diagnostic methods

    By Timo Minssen New publication on the patentability of biomedical diagnostics out: Abstract: This brief comment complements Dan Burk’s excellent paper ( Dolly and Alice, J Law and the Biosciences (2015), 1–21, doi:10.1093/jlb/lsv042 ) by providing…

    Separating sheep from goats- a European view on the patent eligibility of biomedical diagnostic methods

    By

    Timo Minssen

  • Biotechnology

    Sequenom vs. Ariosa and international approaches to the patent eligibility of biomedical innovation

    By Timo Minssen With a potential petition for writ of certiorari in the Sequenom v. Ariosa case approaching, it appears as if the US Supreme Court  will once again have to consider crucial patent eligibility questions with a great significance for biomedical…

    Sequenom vs. Ariosa and international approaches to the patent eligibility of biomedical innovation

    By

    Timo Minssen